These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32972546)

  • 21. Clinical clues for suspecting wild-type transthyretin cardiac amyloidosis in patients with monoclonal gammopathy of undetermined significance: a case report.
    Haga T; Okumura T; Harada Y; Hiraiwa H; Morimoto R; Kaneko S; Kato N; Shinoda M; Murohara T
    Egypt Heart J; 2024 Jun; 76(1):74. PubMed ID: 38856864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis.
    Henein MY; Suhr OB; Arvidsson S; Pilebro B; Westermark P; Hörnsten R; Lindqvist P
    Amyloid; 2018 Mar; 25(1):46-53. PubMed ID: 29369708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous cardioversion and mitral valve repair: a role for surgical cardioversion (Cox-maze)?
    Large SR; Hosseinpour AR; Wisbey C; Wells FC
    Eur J Cardiothorac Surg; 1997 Jan; 11(1):76-80. PubMed ID: 9030793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real-World Data.
    Müller ML; Latinova E; Brand A; Mattig I; Spethmann S; Messroghli D; Hahn K; Landmesser U; Heidecker B
    J Am Heart Assoc; 2024 Jul; ():e033478. PubMed ID: 38958150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis.
    Griffin JM; Chiu L; Axsom KM; Bijou R; Clerkin KJ; Colombo P; Cuomo MO; De Los Santos J; Fried JA; Goldsmith J; Habal M; Haythe J; Helmke S; Horn EM; Latif F; Hi Lee S; Lin EF; Naka Y; Raikhelkar J; Restaino S; Sayer GT; Takayama H; Takeda K; Teruya S; Topkara V; Tsai EJ; Uriel N; Yuzefpolskaya M; Farr MA; Maurer MS
    Clin Transplant; 2020 Oct; 34(10):e14028. PubMed ID: 32623785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?
    Aus dem Siepen F; Hein S; Prestel S; Baumgärtner C; Schönland S; Hegenbart U; Röcken C; Katus HA; Kristen AV
    Clin Res Cardiol; 2019 Dec; 108(12):1324-1330. PubMed ID: 30953182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence of sinus rhythm in patients with "permanent" atrial fibrillation.
    Ziegler PD; Sakaguchi S; Simons GR; Koehler JL; Warman E
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):674-81. PubMed ID: 24499313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of recurrence rates after direct-current cardioversion for new-onset atrial fibrillation in patients receiving versus those not receiving rhythm-control drug therapy.
    Li H; Riedel R; Oldemeyer JB; Rovang K; Hee T
    Am J Cardiol; 2004 Jan; 93(1):45-8. PubMed ID: 14697464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left atrial pressure pattern without a-wave in sinus rhythm after cardioversion affects the outcomes after catheter ablation for atrial fibrillation.
    Kishima H; Mine T; Takahashi S; Ashida K; Ishihara M; Masuyama T
    Heart Vessels; 2018 Nov; 33(11):1365-1372. PubMed ID: 29691642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage.
    Law S; Petrie A; Chacko L; Cohen OC; Ravichandran S; Gilbertson JA; Rowczenio D; Wechalekar A; Martinez-Naharro A; Lachmann HJ; Whelan CJ; Hutt DF; Hawkins PN; Fontana M; Gillmore JD
    ESC Heart Fail; 2020 Dec; 7(6):3942-3949. PubMed ID: 32924285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Atrial fibrillation: always cardioversion? No].
    Di Pasquale G; Biancoli S; Sassone B; Pancaldi LG
    Ital Heart J Suppl; 2002 Jan; 3(1):81-90. PubMed ID: 11899578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications.
    Balciunaite G; Rimkus A; Zurauskas E; Zaremba T; Palionis D; Valeviciene N; Aidietis A; Serpytis P; Rucinskas K; Sogaard P; Glaveckaite S; Zorinas A; Janusauskas V
    Hellenic J Cardiol; 2020; 61(2):92-98. PubMed ID: 31740363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time to cardioversion of recurrent atrial arrhythmias after catheter ablation of atrial fibrillation and long-term clinical outcome.
    Baman TS; Gupta SK; Billakanty SR; Ilg KJ; Good E; Crawford T; Jongnarangsin K; Ebinger M; Pelosi F; Bogun F; Chugh A; Morady F; Oral H
    J Cardiovasc Electrophysiol; 2009 Dec; 20(12):1321-5. PubMed ID: 19602031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation].
    Potpara T; Marinković-Erić J; Grujić M; Radojković-Cirović B; Vujisić-Tesić B; Petrović M
    Srp Arh Celok Lek; 2002; 130(5-6):189-92. PubMed ID: 12395441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.
    Goland S; Volodarsky I; Fabricant Y; Livschitz S; Tshori S; Cuciuc V; Zilberman L; Fugenfirov I; Meledin V; Shimoni S; Josfberg S; George J
    PLoS One; 2021; 16(7):e0254104. PubMed ID: 34242301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-reported sleep quality of patients with atrial fibrillation and the effects of cardioversion on sleep quality.
    Kayrak M; Gul EE; Aribas A; Akilli H; Alibasiç H; Abdulhalikov T; Yildirim O; Yazici M; Ozdemir K
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):823-9. PubMed ID: 23437796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
    Paton DM
    Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Computed Tomography-Based Evaluation of Myocardial Extracellular Volume Combined With Red Flags for Early Screening of Concealed Cardiac Amyloidosis in Patients With Atrial Fibrillation.
    Yamasaki H; Kondo H; Shiroo T; Iwata N; Masuda T; Makita T; Iwabuchi Y; Tanazawa K; Takahashi M; Ono Y; Ogawa N; Harada T; Mitarai K; Yamauchi S; Takano M; Kodama N; Hirota K; Miyoshi M; Yonezu K; Tawara K; Abe I; Saito S; Fukui A; Fukuda T; Akioka H; Shinohara T; Akiyoshi K; Teshima Y; Yufu K; Daa T; Matsubara E; Asayama Y; Ueda M; Takahashi N
    Circ J; 2024 Jun; 88(7):1167-1175. PubMed ID: 38522901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).
    Phull P; Sanchorawala V; Connors LH; Doros G; Ruberg FL; Berk JL; Sarosiek S
    Amyloid; 2018 Mar; 25(1):62-67. PubMed ID: 29424556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When and how do patients with cardiac amyloidosis die?
    Escher F; Senoner M; Doerler J; Zaruba MM; Messner M; Mussner-Seeber C; Ebert M; Ensinger C; Mair A; Kroiss A; Ulmer H; Schneiderbauer-Porod S; Ebner C; Poelzl G
    Clin Res Cardiol; 2020 Jan; 109(1):78-88. PubMed ID: 31134330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.